Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Lobitz, StephanTelfer, Paul
Cela, Elena
Allaf, Bichr
Angastiniotis, Michael
Backman Johansson, Carolina
Badens, Catherine
Bento, Celeste
Bouva, Marelle J
Canatan, Duran
Charlton, Matthew
Coppinger, Cathy
Daniel, Yvonne
de Montalembert, Marianne
Ducoroy, Patrick
Dulin, Elena
Fingerhut, Ralph
Frömmel, Claudia
García-Morin, Marina
Gulbis, Béatrice
Holtkamp, Ute
Inusa, Baba
James, John
Kleanthous, Marina
Klein, Jeannette
Kunz, Joachim B
Langabeer, Lisa
Lapouméroulie, Claudine
Marcao, Ana
Marín Soria, José L
McMahon, Corrina
Ohene-Frempong, Kwaku
Périni, Jean-Marc
Piel, Frédéric B
Russo, Giovanna
Sainati, Laura
Schmugge, Markus
Streetly, Allison
Tshilolo, Leon
Turner, Charles
Venturelli, Donatella
Vilarinho, Laura
Yahyaoui, Rachel
Elion, Jacques
Colombatti, Raffaella
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.Published in
Br J Haematol 2018; 183(4):648-660Publiekssamenvatting
Sickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.PMID
30334577ae974a485f413a2113503eed53cd6c53
10.1111/bjh.15600
Scopus Count
Collections
Related articles
- [Newborn screening for sickle cell disease in France].
- Authors: Brousse V, Allaf B, Benkerrou M
- Issue date: 2021 May
- Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
- Authors: Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L
- Issue date: 2019 May
- Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
- Authors: Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D'Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J
- Issue date: 2019 Nov 13
- Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
- Authors: García-Morín M, Bardón-Cancho EJ, Beléndez C, Zamarro R, Béliz-Mendiola C, González-Rivera M, Vecilla C, Llorente-Otones L, Pérez-Alonso V, Román SS, Sebastián E, Dulín E, Cela E
- Issue date: 2020 Jul
- Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
- Authors: Nnachi OC, Umeokonkwo AA, Okoye HC, Ekwe AN, Akpa CO, Okoye AE
- Issue date: 2023 Mar 31